Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

LCFA-CoA inhibits NME1 and regulates cancer metastasis

March 15, 2022

Discovery of novel MDM2 inhibitor with antitumor activity in p53 wild-type cancer models

March 14, 2022

Targeting PTP1B enhances T cell-mediated antitumor immunity

March 14, 2022

Medshine Discovery identifies new cyclin/CDK inhibitors

March 14, 2022

New Bruton tyrosine kinase inhibitors identified at Beijing Innocare Medical Technology

March 14, 2022

TYK2 inhibitors described by Ennovabio (Zhejiang) Pharmaceuticals, Shanghai Ennova Biopharmaceutical

March 14, 2022

Blocking UBE2N evades oncogenic immune signaling in AML

March 14, 2022

Oncternal advances ONCT-808 toward IND filing and ONCT-534 into IND-enabling studies

March 11, 2022

Sunshine Lake Pharma identifies new GTPase KRAS mutant inhibitors

March 11, 2022

Betta Pharmaceuticals presents YAP1 or TAZ/TEAD interaction inhibitors

March 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...